Advertisement

PharmacoEconomics & Outcomes News

, Volume 841, Issue 1, pp 28–28 | Cite as

Switch to infliximab and etanercept biosimilars saves cost in Denmark

Non-clinical study
  • 5 Downloads

Reference

  1. Jensen TB, et al. The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars. European Journal of Clinical Pharmacology : Nov 2019. Available from: URL: http://doi.org/10.1007/s00228-019-02765-3

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations